Published in AIDS Weekly, July 29th, 1996
"We think this vaccine may be protective against some virus strains," said Genentech researcher Donald P. Francis. "The extent, breadth, and duration of such protection awaits initiation and completion of efficacy trials."
Francis and colleague Phillip W. Berman presented data from clinical trials of the Genentech subunit vaccines during separate presentations at the XI...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.